Myriad Genetics Gets (Worldwide) Rights To RAD51C Gene Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, January 19, 2012

Myriad Genetics Gets (Worldwide) Rights To RAD51C Gene



"...Through this agreement, Myriad has obtained an exclusive, world-wide license, with co-exclusivity in Germany, to provide commercial testing for RAD51C."

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.